JPS57167920A - Snore treatment composition - Google Patents

Snore treatment composition

Info

Publication number
JPS57167920A
JPS57167920A JP56196719A JP19671981A JPS57167920A JP S57167920 A JPS57167920 A JP S57167920A JP 56196719 A JP56196719 A JP 56196719A JP 19671981 A JP19671981 A JP 19671981A JP S57167920 A JPS57167920 A JP S57167920A
Authority
JP
Japan
Prior art keywords
treatment composition
snore treatment
snore
composition
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP56196719A
Other languages
English (en)
Other versions
JPH0161086B2 (ja
Inventor
Raikeruto Deietoritsuhi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JPS57167920A publication Critical patent/JPS57167920A/ja
Publication of JPH0161086B2 publication Critical patent/JPH0161086B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP56196719A 1980-12-06 1981-12-07 Snore treatment composition Granted JPS57167920A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3046125 1980-12-06
DE3046484 1980-12-10

Publications (2)

Publication Number Publication Date
JPS57167920A true JPS57167920A (en) 1982-10-16
JPH0161086B2 JPH0161086B2 (ja) 1989-12-27

Family

ID=25789574

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56196719A Granted JPS57167920A (en) 1980-12-06 1981-12-07 Snore treatment composition

Country Status (4)

Country Link
US (2) US4556557A (ja)
EP (1) EP0053754B1 (ja)
JP (1) JPS57167920A (ja)
IT (1) IT1168191B (ja)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08333244A (ja) * 1995-06-06 1996-12-17 Sato Seiyaku Kk いびきの治療または予防用の組成物
JP2008189568A (ja) * 2007-02-02 2008-08-21 Sceti Kk いびき症の予防または治療のための口腔用液状剤用またはフィルム状剤用組成物、及びこれを含む口腔用製品
WO2017022811A1 (ja) * 2015-08-04 2017-02-09 日東薬品工業株式会社 いびきの防止または改善用乳化組成物

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4970220A (en) * 1982-05-17 1990-11-13 S. C. Johnson & Son, Inc. Skin conditioning composition
CH657779A5 (de) * 1982-10-05 1986-09-30 Sandoz Ag Galenische zusammensetzungen enthaltend calcitonin.
AU574360B2 (en) * 1983-05-13 1988-07-07 Reichert, D. Antisnoring agent
CA1291036C (en) * 1986-04-23 1991-10-22 Edwin I. Stoltz Nasal administration of drugs
DE3832401A1 (de) * 1988-09-23 1990-03-29 Cassella Ag Pharmazeutische zubereitung zur behandlung entzuendeter nasenschleimhaeute
DE19517251A1 (de) * 1995-05-11 1996-11-14 Klosterfrau Mcm Vetrieb Gmbh Verwendung von Dexpanthenol zur Behandlung trockener Nasenschleimhäute
US5603935A (en) * 1995-07-29 1997-02-18 Eastern Europe, Inc. Composition for the treatment of snoring and methods of use thereof
US5618543A (en) * 1995-08-08 1997-04-08 Harris; Dennis H. Composition and method for reducing snoring and respiratory problems
US5804211A (en) * 1996-06-05 1998-09-08 Health Pharm Usa, Inc. Composition and method for suppressing or eliminating snoring
US5891469A (en) * 1997-04-02 1999-04-06 Pharmos Corporation Solid Coprecipitates for enhanced bioavailability of lipophilic substances
DE29723959U1 (de) 1997-07-22 1999-07-22 Zellner Nasenspray-Flüssigkeit
DE19731472C2 (de) * 1997-07-22 2000-05-25 Gerhard Zellner Nasenspray-Flüssigkeit
US6022551A (en) * 1998-01-20 2000-02-08 Ethicon, Inc. Antimicrobial composition
US6248343B1 (en) 1998-01-20 2001-06-19 Ethicon, Inc. Therapeutic antimicrobial compositions
US6187318B1 (en) * 1998-10-29 2001-02-13 Innovative Chemical Corporation Anti-snoring composition
US8173709B2 (en) 1999-09-22 2012-05-08 Quadex Pharmaceuticals, Llc Anti-infective methods for treating pathogen-induced disordered tissues
EP1218023B8 (en) 1999-10-01 2006-05-03 Johnson & Johnson Consumer Companies, Inc. Method for calming human beings using personal care compositions
US6790465B2 (en) 2000-12-01 2004-09-14 Snore-Fix, Inc. Composition and method for treating snoring
US20020146469A1 (en) * 2000-12-20 2002-10-10 Benjamin Wiegand Methods for reducing chronic stress in mammals
US20020151527A1 (en) * 2000-12-20 2002-10-17 Benjamin Wiegand Method for reducing acne or improving skin tone
CA2443105C (en) 2001-04-06 2011-11-08 The Board Of Trustees Of The University Of Illinois Functional role for cannabinoids in autonomic stability during sleep
US6652842B2 (en) 2001-11-13 2003-11-25 Noville, Inc. Deodorant compositions comprising diglycerol
US6770264B2 (en) 2001-11-13 2004-08-03 Noville, Inc. Chewing gum compositions comprising diglycerol
US6723304B2 (en) 2001-11-13 2004-04-20 Noville, Inc. Oral care compositions comprising diglycerol
KR20030063671A (ko) * 2002-01-23 2003-07-31 주식회사 바이오레인 코골이 치료용 조성물
GB2384563A (en) * 2002-01-29 2003-07-30 Johnson & Johnson Consumer Method of measuring the stress or relaxation level of a mammal
GB0203045D0 (en) * 2002-02-08 2002-03-27 Johnson & Johnson Consumer Method of afefecting sleep and sleep-related behaviours
WO2003070178A2 (en) * 2002-02-15 2003-08-28 Cns, Inc. Throat spray
US7423004B2 (en) * 2003-01-31 2008-09-09 Smithkline Beecham Corporation Solid dispersion compositions
US20040175438A1 (en) * 2003-03-03 2004-09-09 Benjamin Wiegand Methods for alleviating symptoms associated with menopause using sensory regimen
DE102007052380A1 (de) * 2007-10-31 2009-05-07 Bitop Ag Osmolythaltige Zubereitungen zur Anwendung bei trockenen Schleimhäuten
US20170202835A1 (en) * 2007-10-31 2017-07-20 Bitop Ag Osmolyte-containing preparation for the treatment of dry mucous membranes
DE102008039231A1 (de) 2008-08-22 2010-02-25 Bitop Ag Verwendung von Glucosylglycerol
US8846725B2 (en) 2011-01-24 2014-09-30 Quadex Pharmaceuticals, Llc Highly penetrating compositions and methods for treating pathogen-induced disordered tissues
US9463180B2 (en) 2013-03-14 2016-10-11 Quadex Pharmaceuticals, Llc Treatment of molluscum contagiosum
US9125911B2 (en) 2013-03-14 2015-09-08 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered tissues
US9549930B2 (en) 2013-03-14 2017-01-24 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered and/or prodromal stage tissue
US20170182063A1 (en) * 2014-08-08 2017-06-29 Shenzhen Hightide Biopharmaceutical, Ltd Liquid formulation compositions, medicament delivery devices, and methods of preparation and use thereof
DK201400720A1 (en) * 2014-12-11 2015-08-24 Tannermedico As Anti-Snoring Composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2989437A (en) * 1955-06-08 1961-06-20 Upjohn Co Anti-inflammatory and anti-bacterial decongestant nasal spray compositions
IT1082339B (it) * 1977-02-07 1985-05-21 Zambelletti Dr L Spa Composto ad attivita disinfettante e composizioni farmaceutiche che lo contengono
GB1599159A (en) * 1977-02-08 1981-09-30 Roussel Lab Ltd Pharmaceutical compositions containing chlorhexidine
US4259323A (en) * 1980-03-24 1981-03-31 Hoffmann-La Roche Inc. Potassium chloride emulsion

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08333244A (ja) * 1995-06-06 1996-12-17 Sato Seiyaku Kk いびきの治療または予防用の組成物
JP2008189568A (ja) * 2007-02-02 2008-08-21 Sceti Kk いびき症の予防または治療のための口腔用液状剤用またはフィルム状剤用組成物、及びこれを含む口腔用製品
WO2017022811A1 (ja) * 2015-08-04 2017-02-09 日東薬品工業株式会社 いびきの防止または改善用乳化組成物
JPWO2017022811A1 (ja) * 2015-08-04 2018-06-14 日東薬品工業株式会社 いびきの防止または改善用乳化組成物

Also Published As

Publication number Publication date
US4556557A (en) 1985-12-03
EP0053754A1 (de) 1982-06-16
EP0053754B1 (de) 1986-04-23
IT1168191B (it) 1987-05-20
JPH0161086B2 (ja) 1989-12-27
IT8125451A0 (it) 1981-12-04
US4668513A (en) 1987-05-26

Similar Documents

Publication Publication Date Title
JPS57167920A (en) Snore treatment composition
DE3377263D1 (en) Skin treatment composition
DE3380762D1 (en) Skin treatment compositions
DE3170572D1 (en) Tobacco treatment
JPS57158715A (en) Skin treatment composition
JPS5634621A (en) Dimethylsulfoxideecontaining treating composition
JPS56148275A (en) Tobacco treatment
DE3372843D1 (en) Skin treatment compositions
GB2131695B (en) Sterilising
JPS5780316A (en) Injury healing promoting composition
IL62264A0 (en) Composition for the treatment of hair
GB8317357D0 (en) Therapeutic composition
JPS57181011A (en) Nadrol composition for glaucoma treatment
JPS55120514A (en) Composition for local treatment
GB2047920B (en) Dental treatment installation
JPS57119826A (en) Improvement regarding substance treatment
EP0051789A3 (en) Therapeutic composition
JPS5782305A (en) Dental treatment composition
JPS5729677A (en) Fixation composition
ZA834402B (en) Skin treatment compositions
JPS56148359A (en) Treating appliance for bruxism
ZA83662B (en) Skin treatment composition
JPS5761651A (en) Under treatment composition
GB2100714B (en) Sewage treatment composition
JPS5756357A (en) Under treatment composition